Evidence map›Paper›PMID 27951632›Full record

ArticleJournal of preventive medicine and public health = Yebang Uihakhoe chi2016

Effects of Antiretroviral Therapy on the Survival of Human Immunodeficiency Virus-positive Adult Patients in Andhra Pradesh, India: A Retrospective Cohort Study, 2007-2013.

Ram Bajpai, Himanshu Chaturvedi, Lakshmanan Jayaseelan, Pauline Harvey, Nicole Seguy, Laxmikant Chavan, Pinnamaneni Raj, Arvind Pandey

Abstract read
In one paragraph

Article in Journal of preventive medicine and public health = Yebang Uihakhoe chi, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ram BajpaiDepartment of Community Medicine, Army College of Medical Sciences, New Delhi, India.ORCID 0000-0002-1227-2703
Himanshu ChaturvediNational Institute of Medical Statistics, New Delhi, India.
Lakshmanan JayaseelanDepartment of Biostatistics, Christian Medical College, Vellore, India.
Pauline HarveyDivision of Global HIV/AIDS, Centers for Disease Control and Prevention, New Delhi, India.
Nicole SeguyWorld Health Organization Country Office for India, New Delhi, India.
Laxmikant ChavanWorld Health Organization Country Office for India, New Delhi, India.
Pinnamaneni RajNational AIDS Control Organization, New Delhi, India.
Arvind PandeyNational Institute of Medical Statistics, New Delhi, India.

Funding

World Health Organization 001
6 · The paper itself

Abstract

objectivesThe survival outcomes of antiretroviral treatment (ART) programs have not been systematically evaluated at the state level in India. This retrospective study assessed the survival rates and factors associated with survival among adult human immunodeficiency virus (HIV)-infected patients in Andhra Pradesh, India.

methodsThe present study used data from 139 679 HIV patients aged ≥15 years on ART who were registered from 2007 to 2011 and were followed up through December 2013. The primary end point was death of the patient. Mortality densities (per 1000 person-years) were calculated. Kaplan-Meier and Cox-regression models were used to estimate survival and explore the factors associated with survival.

resultsThe overall median follow-up time was 16.0 months (2.0 months for the deceased and 14.0 months for those lost to follow-up). Approximately 13.2% of those newly initiated on ART died during follow-up. Of those deaths, 56% occurred in the first three months. The crude mortality rate was 80.9 per 1000 person-years at risk. The CD4 count (adjusted hazard ratio [aHR],4.88; 95% confidence interval [CI], 4.36 to 5.46 for <100 cells/mm

conclusionsThe study findings revealed that high mortality was observed within the first three months of ART initiation. Patients with poor baseline clinical characteristics had a higher risk of mortality. Expanded testing and counseling should be encouraged, with the goal of ensuring early enrollment into the program followed by the initiation of ART in HIV-infected patients.

Indexed as

AdultAnti-Retroviral AgentsCD4-Positive T-LymphocytesCohort StudiesFemaleHIV InfectionsHumansKaplan-Meier EstimateMaleMiddle AgedRetrospective StudiesAnti-Retroviral AgentsAcquired immunodeficiency syndromeAdultAntiretroviral therapyCD4 lymphocyte countIndiaSurvival analysis

Identifiers

PMID27951632
PMCPMC5160137

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.